Home
>
US Stocks
>
INmune Bio Inc
INmune Bio Inc
INMB

INmune Bio Inc

$18.750.48%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
18.14
Today Low/High
17.84 / 18.75
52 Week Low/High
$7.28 / $30.37
Market Cap
$325.61M

Company Details

INmune Bio, Inc. is a publicly traded, clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. INmune Bio has two product platforms. The DN-TNF product platform utilizes dominant-negative technology to selectively neutralize soluble TNF, a key driver of innate immune dysfunction and mechanistic target of many diseases. The Natural Killer Cell Priming Platform includes INKmune™ aimed at priming the patient's NK cells to eliminate minimal residual disease in patients with cancer. INmune Bio's product platforms utilize a precision medicine approach for the treatment of a wide variety of hematologic malignancies, solid tumors and chronic inflammation.
Organisation
INmune Bio Inc
Employees
5
Industry
Medical Specialties

Discover more

Frequently Asked Questions

What is INmune Bio Inc share price today

Can Indians buy INmune Bio Inc shares?

How can I buy INmune Bio Inc shares from India?

Can Fractional shares of INmune Bio Inc be purchased?

What are the documents required to start investing in INmune Bio Inc stocks?

We are a SEBI registered investement advisor